J.B. Chemicals & Pharmaceuticals Ltd. receives ANDA approval from US FDA

The US FDA has approved J.B. Chemicals & Pharmaceuticals Ltd.'s Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg (for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy) for over-the-counter (OTC) use. This product is generic version of Clartin® tablet in the same strength of Bayer Healthcare LLC.

The Company expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve Company's US sales.

Shares of J.B.CHEMICALS & PHARMACEUTICALS LTD. was last trading in BSE at Rs.1044.1 as compared to the previous close of Rs. 1034.95. The total number of shares traded during the day was 33813 in over 3477 trades.

The stock hit an intraday high of Rs. 1078 and intraday low of 1027.05. The net turnover during the day was Rs. 35649036.

Source : Equity Bulls

Keywords